BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38415495)

  • 21. Withdrawn: Biomarkers in Disease Diagnosis and the Role of LC-MS and NMR: A Review.
    Ashaq I; Ahmad Sheikh A; Beri N; Mittal S; Javed Naim M; Alam O; Bawa S
    Curr Pharm Des; 2022 Apr; ():. PubMed ID: 35410591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal Notice: Design and Development of Key Chain Held Insulin injectable device.
    Manarvi IA; Matta NM
    Curr Diabetes Rev; 2020 Jul; ():. PubMed ID: 32619171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal Notice: Circulatory Cells as Tumortropic Carrier for Targetability Improvement.
    Zou D; Weng Y; Yang P
    Curr Drug Deliv; 2020 Nov; ():. PubMed ID: 33234105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WITHDRAWN: Computational Chemistry in the Fight Against SARSCoV-2.
    Khan A; Wei DQ
    Comb Chem High Throughput Screen; 2022 Jan; ():. PubMed ID: 35021969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withdrawal Notice: Investigation of the Use of Neural Networks for Diagnosing Breast Cancer on Mammograms.
    Ivanova GS; Golovkov AA; Petrova IS; Borodin AA; Shakhlan AO; Umnov AV; Lonshakova KA; Kelenin VV
    Curr Med Imaging; 2021 Jul; ():. PubMed ID: 34238166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WITHDRAWN: Evaluation of Morphine, Methadone, Digoxin, and Dronabinol Poisoning in Shahid Mostafa Khomeini Hospital in Ilam, Iran.
    Saki K; Bahmani M; Zamanian G; Shokri S; Aidy A; Manouchehri A
    Curr Drug Res Rev; 2022 Nov; ():. PubMed ID: 36420880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notice of Withdrawal.
    Curr Top Med Chem; 2019 Nov; ():. PubMed ID: 31724501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notice of Withdrawal.
    Curr Top Med Chem; 2019 Nov; ():. PubMed ID: 31724499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notice of Withdrawal.
    Curr Cancer Drug Targets; 2017 Jun; ():. PubMed ID: 28669348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Withdrawal: Advances in Development of Drugs for Chronic Myelogenous Leukemia.
    Zhang Y; Wu X; Sun X; Yang J; Liu C; Tang G; Lei X; Huang H; Peng J
    Mini Rev Med Chem; 2022 Apr; ():. PubMed ID: 35379145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Withdrawal Notice: Morphology of Coronary Arteries in Relation to Ischemic Heart Disease.
    Leone A
    Curr Pharm Des; 2021 Jan; ():. PubMed ID: 33463453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withdrawal Notice: Management of Right Atrial Thrombus. Where is the Evidence? : A Narrative Review.
    Sheikh O; Gulick D; Saenger E; Parmar R; Chilton R; Bailey S
    Curr Cardiol Rev; 2019 Oct; ():. PubMed ID: 31657680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WITHDRAWN: Main Diagnostic Methods for COVID-19: Integrative Review.
    de Campos ASM; de Souza GAF; de Jesus RA; Zardeto G; Donadel G; Dalmagro M; de Almeida Canoff JR; Hoscheid J; Alberton O; Boleta-Ceranto DCF; Gonçalves DD; Botelho Lourenço EL; Cogo J
    Curr Pharm Des; 2022 May; ():. PubMed ID: 35619252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WITHDRAWN: Therapeutic Targeted Approaches for Covid-19 Treatment.
    Rajawat J; Misra G; Anvikar AK; Era B
    Curr Pharm Biotechnol; 2022 Mar; ():. PubMed ID: 35249480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal Notice: Mortality, prevalence, and possible therapeutics to treat diabetic patients infected with nCOVID-19.
    Ashique S; Sandhu NK
    Curr Diabetes Rev; 2021 Feb; ():. PubMed ID: 33593262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WITHDRAWN: Anti-lung Cancer Mechanism of Hedyotis Diffusa Willd Based on Network Pharmacology and Molecular Docking.
    Huang F; Xu L; Niu W; Pang J; Li S; Li X
    Comb Chem High Throughput Screen; 2022 Aug; ():. PubMed ID: 36043773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal Notice: Lead Optimization from Natural Ligands by In-Silico Approach for Discovering Potential Monoamine Oxidasesinhibitors (MAOIs).
    Dhiman P; Malik N; Khatkar A
    Curr Drug Metab; 2020 May; ():. PubMed ID: 32357811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WITHDRAWN: Conjugation of Ruthenium Drugs to Nanocellulose using Boronic Ester.
    Lu M; Khine YY; Shen Y; Stenzel MH
    Curr Drug Deliv; 2023 Feb; ():. PubMed ID: 36797605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WITHDRAWN: Recent Advances of Nanotechnology in the Treatment of Skin Cancer.
    Kanugo A
    Curr Pharm Biotechnol; 2022 Apr; ():. PubMed ID: 35379144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal Notice: Applying Peer Mentoring to Improve Learning Human Anatomy.
    Nikolenko VN; Rizaeva NA; Oganesyan MV; Kudryashova VA; Dubrovina PI; Dubovets AA; Bolotskaya AA; Bulygin KV; Muresanu C; Somasundaram SG; Kirkland CE; Aliev G
    Cent Nerv Syst Agents Med Chem; 2021 Feb; ():. PubMed ID: 33583385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.